Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / Common Stock, no par value
-
Shares outstanding
-
109,272,143
-
Number of holders
-
18
-
Total 13F shares, excl. options
-
586,197
-
Shares change
-
+586,197
-
Total reported value, excl. options
-
$3,220,392
-
Value change
-
+$3,220,392
-
Number of buys
-
18
-
Price
-
$5.43
Institutional Holders of ONCOLYTICS BIOTECH INC - Common Stock, no par value (ONCY) as of Q2 2018
As of 30 Jun 2018 ONCOLYTICS BIOTECH INC - Common Stock, no par value (ONCY) had 18 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 586,197 shares of stock of the company.
Largest 10 holders included MILLENNIUM MANAGEMENT LLC, MORGAN STANLEY, COMERICA BANK, ROYAL BANK OF CANADA, Federation des caisses Desjardins du Quebec, BANK OF MONTREAL /CAN/, UBS Group AG, DEUTSCHE BANK AG\, BANK OF AMERICA CORP /DE/, and CITIGROUP INC.
This table shows 18 institutional shareholders of the security as of 30 Jun 2018.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.